Researcher.Life Logo

Clinical and Translational Radiation Oncology : Impact Factor & More

eISSN: 2405-6308pISSN: 2405-6308
JournalOpen Access

Aims and Scope of Clinical and Translational Radiation Oncology

Clinical and Translational Radiation Oncology is an international, open access journal which encompasses all aspects of clinical and translational radiation oncology research, particularly new developments in experimental radiobiology, clinical interventions and treatments. This includes imaging and biomarker studies with clinical endpoints, as well as research results from data sciences, epidemiology, and oncopolicy. Less

Key Metrics

CiteScore
6.8
Impact Factor
< 5
SJR
Q2Oncology
SNIP
1.51
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Clinical and Translational Radiation Oncology

Clinical and Translational Radiation Oncology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher ELSEVIER IRELAND LTD
Language English
Frequency Bi-monthly
Article Processing ChargesEUR 1720
Publication Time28
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorEuropean Society for Radiotherapy and Oncology
FrequencyBi-monthly
Publication Start Year2016
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 28
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Clinical and Translational Radiation Oncology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Clinical and Translational Radiation Oncology

Organ preservation in rectal cancer following clinical complete response after short-course radiotherapy-based total neoadjuvant therapy.
  • 1 Sep 2026
  • Clinical and translational radiation oncology
Patient selection and toxicity predictors in proton reirradiation for locoregional breast cancer recurrence.
  • 1 Sep 2026
  • Clinical and translational radiation oncology
Moving beyond anatomy: the future of rectal cancer management is biologically-informed, response-adapted, and patient-centered.
  • 1 Sep 2026
  • Clinical and translational radiation oncology
Radiotherapy quality assurance in the PRO-GLIO trial: results from a dummy run comparing experts across twelve institutions in two Scandinavian countries.
  • 1 Sep 2026
  • Clinical and translational radiation oncology
Corrigendum to "Pre-Treatment and Pre-Brachytherapy MRI First-Order Radiomic Features by a Commercial Software as Survival Predictors in Radiotherapy for Cervical Cancer" [Clin. Transl. Radiat. Oncol. 53 (2025) 100965
  • 1 Jul 2026
  • Clinical and translational radiation oncology
Indication adherence and outcome of post-operative radiotherapy in oral cavity cancer patients with intermediate adverse pathological tumor features: A nationwide population-based analysis.
  • 1 Jul 2026
  • Clinical and translational radiation oncology
Organ preservation in rectal cancer following clinical complete response after short-course radiotherapy-based total neoadjuvant therapy.
  • 1 Sep 2026
  • Clinical and translational radiation oncology
Patient selection and toxicity predictors in proton reirradiation for locoregional breast cancer recurrence.
  • 1 Sep 2026
  • Clinical and translational radiation oncology
Moving beyond anatomy: the future of rectal cancer management is biologically-informed, response-adapted, and patient-centered.
  • 1 Sep 2026
  • Clinical and translational radiation oncology
Radiotherapy quality assurance in the PRO-GLIO trial: results from a dummy run comparing experts across twelve institutions in two Scandinavian countries.
  • 1 Sep 2026
  • Clinical and translational radiation oncology
Corrigendum to "Pre-Treatment and Pre-Brachytherapy MRI First-Order Radiomic Features by a Commercial Software as Survival Predictors in Radiotherapy for Cervical Cancer" [Clin. Transl. Radiat. Oncol. 53 (2025) 100965
  • 1 Jul 2026
  • Clinical and translational radiation oncology
Indication adherence and outcome of post-operative radiotherapy in oral cavity cancer patients with intermediate adverse pathological tumor features: A nationwide population-based analysis.
  • 1 Jul 2026
  • Clinical and translational radiation oncology

FAQs on Clinical and Translational Radiation Oncology